Concepedia

Geoffrey L. Uy

GL

136

Publications

12.7K

Citations

53

H-Index

1997

Active since

Affiliations

Washington University in St. Louis(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

The Ohio State University

Memorial Sloan Kettering Cancer Center

Geoffrey L. Uy is an author at Washington University in St. Louis specializing in medicine, hematology, and oncology.

ORCID

Top concepts

Publications per year

1997–2025

136

Publications

136

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2018 · 958 citations · Full text

, , +16

<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

John S. Welch, Allegra A. Petti, Christopher A. Miller et al. · New England Journal of Medicine · 2016 · 774 citations · Full text

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Bruno Nervi, Pablo Ramírez, Michael P. Rettig et al. · Blood · 2008 · 477 citations · Full text

A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia

Geoffrey L. Uy, Michael P. Rettig, Ibraheem Motabi et al. · Blood · 2012 · 381 citations · Full text

Rows per page

1–5 of 136